GOLDEN RHINO Trademark
Trademark Overview
On Wednesday, March 5, 1997, a trademark application was filed for GOLDEN RHINO with the United States Patent and Trademark Office. The USPTO has given the GOLDEN RHINO trademark a serial number of 75258843. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, July 27, 2000. This trademark is owned by NexMed, Inc.. The GOLDEN RHINO trademark is filed in the Medical Instrument Products category with the following description:
applicator for delivering a drug useful for treating male erectile dysfunction
General Information
Serial Number | 75258843 |
Word Mark | GOLDEN RHINO |
Filing Date | Wednesday, March 5, 1997 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, July 27, 2000 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | applicator for delivering a drug useful for treating male erectile dysfunction |
Classification Information
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, April 3, 1997 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | NexMed, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Commerce, CA 90040 |
Trademark Events
Event Date | Event Description |
Thursday, July 27, 2000 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Friday, November 5, 1999 | NON-FINAL ACTION MAILED |
Thursday, September 3, 1998 | ASSIGNED TO EXAMINER |
Thursday, September 25, 1997 | LETTER OF SUSPENSION MAILED |
Tuesday, September 23, 1997 | ASSIGNED TO EXAMINER |